Medclair AB (NGM:MCLR)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.960
-0.100 (-3.27%)
At close: Sep 3, 2026

Medclair AB Statistics

Total Valuation

Medclair AB has a market cap or net worth of SEK 271.28 million. The enterprise value is 252.41 million.

Market Cap271.28M
Enterprise Value 252.41M

Important Dates

The next estimated earnings date is Monday, November 2, 2026.

Earnings Date Nov 2, 2026
Ex-Dividend Date n/a

Share Statistics

Medclair AB has 91.65 million shares outstanding.

Current Share Class 91.65M
Shares Outstanding 91.65M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 13.39%
Owned by Institutions (%) 17.91%
Float 64.49M

Valuation Ratios

The trailing PE ratio is 183.42.

PE Ratio 183.42
Forward PE n/a
PS Ratio 5.01
PB Ratio 3.45
P/TBV Ratio 6.16
P/FCF Ratio 201.69
P/OCF Ratio 189.04
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 36.37, with an EV/FCF ratio of 187.66.

EV / Earnings 170.66
EV / Sales 4.66
EV / EBITDA 36.37
EV / EBIT 117.84
EV / FCF 187.66

Financial Position

The company has a current ratio of 3.84

Current Ratio 3.84
Quick Ratio 2.38
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage 10.60

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 3.61%
Return on Capital Employed (ROCE) 2.72%
Weighted Average Cost of Capital (WACC) 8.44%
Revenue Per Employee 3.61M
Profits Per Employee 98,600
Employee Count15
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -4.52% in the last 52 weeks. The beta is 0.76, so Medclair AB's price volatility has been lower than the market average.

Beta (5Y) 0.76
52-Week Price Change -4.52%
50-Day Moving Average 2.84
200-Day Moving Average 2.66
Relative Strength Index (RSI) 55.00
Average Volume (20 Days) 228,238

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Medclair AB had revenue of SEK 54.13 million and earned 1.48 million in profits.

Revenue54.13M
Gross Profit 34.86M
Operating Income 2.14M
Pretax Income 1.48M
Net Income 1.48M
EBITDA 6.94M
EBIT 2.14M
Earnings Per Share (EPS) n/a
Full Income Statement

Balance Sheet

The company has 18.87 million in cash and no debt, with a net cash position of 18.87 million or 0.21 per share.

Cash & Cash Equivalents 18.87M
Total Debt n/a
Net Cash 18.87M
Net Cash Per Share 0.21
Equity (Book Value) 78.73M
Book Value Per Share n/a
Working Capital 38.71M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.44 million and capital expenditures -90,000, giving a free cash flow of 1.35 million.

Operating Cash Flow 1.44M
Capital Expenditures -90,000
Depreciation & Amortization 4.80M
Net Borrowing n/a
Free Cash Flow 1.35M
FCF Per Share 0.01
Full Cash Flow Statement

Margins

Gross margin is 64.40%, with operating and profit margins of 3.96% and 2.73%.

Gross Margin 64.40%
Operating Margin 3.96%
Pretax Margin 2.73%
Profit Margin 2.73%
EBITDA Margin 12.82%
EBIT Margin 3.96%
FCF Margin 2.48%

Dividends & Yields

Medclair AB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield 0.55%
FCF Yield 0.50%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2